13F Holdings
中文EN

PRVA Privia Health Group, Inc.

Services-Health Services · Nasdaq · SEC CIK 1759655 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY19.2%
TTM net income YoY91.3%
TTM EPS YoY85.7%
Revenue 3-yr CAGR15.5%
Net income 3-yr CAGR-3.0%

Margins

Gross margin—
Operating margin2.1%
Net margin1.4%
FCF margin—
EBITDA margin2.6%

Returns

ROE4.6%
ROA2.4%
ROIC (approx.)10.0%
Asset turnover1.67x

Leverage & solvency

Liabilities / assets44.2%
Debt / equity0.00x
Current ratio1.63x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.11x
Accruals ratio-5.0%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$2.12B$1.74B$1.66B$1.36B$966.22M
SG&A expense$138.15M$126.16M$109.59M$129.59M$255.88M
Operating income$34.23M$16.98M$20.65M-$19.12M-$217.44M
Interest expense———$500,000$1.10M
Pretax income$43.94M$27.87M$29.02M-$18.58M-$218.51M
Income tax$14.21M$10.83M$7.99M-$6.52M-$27.86M
Net income$22.92M$14.38M$23.08M-$8.59M-$188.23M
EBITDA$44.14M$24.25M$27.18M-$14.55M-$214.97M
EPS (basic)0.190.120.20-0.08-1.83
EPS (diluted)0.180.110.19-0.08-1.83
Weighted avg. shares (diluted)128.89M125.61M124.69M110.70M102.95M
Banking
Net interest income——$8.37M$542,000-$1.07M
Balance sheet
Cash & equivalents$479.69M$491.15M$389.51M$347.99M$320.58M
Receivables$400.90M$316.18M$290.77M$189.60M$117.40M
Current assets$911.00M$834.82M$700.80M$551.96M$446.68M
PP&E, net$504,000$1.24M$2.33M$3.39M$4.50M
Goodwill$209.84M$141.62M$138.75M$126.94M$127.94M
Intangibles$215.92M$109.81M$107.63M$57.39M$59.74M
Total assets$1.37B$1.14B$999.90M$792.81M$686.37M
Current liabilities$568.52M$449.15M$386.95M$264.27M$190.46M
Total liabilities$578.43M$452.34M$392.51M$273.76M$236.19M
Shareholders' equity$737.22M$635.18M$561.44M$499.09M$426.87M
Shares outstanding123.60M120.31M118.22M114.69M107.84M
Cash flow statement
Operating cash flow$163.40M$109.28M$80.78M$47.20M$55.06M
Capital expenditure——$113,000$104,000$547,000
Free cash flow——$80.67M$47.09M$54.51M
Investing cash flow-$181.57M-$11.98M-$42.97M-$104,000-$32.77M
Financing cash flow$6.70M$4.33M$3.71M-$19.68M$213.66M
Depreciation & amortization$9.91M$7.27M$6.53M$4.57M$2.46M
Stock-based compensation$71.07M$56.68M$37.10M$67.36M$253.53M

Free plan shows the latest 5 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.